Phase III trial of docetaxel (D) and carboplatin (CBDCA) as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Giannakakis, Th; Mavroudis, D; Papadouris, S; Kourousis, Ch; Ziras, N; Kakolyris, S; Kalbakis, K; Agelaki, S; Zianni, D; Zianni, V; Lidaki, E; Vakaloudi, N; Papadakis, E; Androulakis, N; Souklakos, J; Kois, S; Sarra, E; Hatzidaki, D; Georgoulias, V

• Book ID: 118575459
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 224 KB
• Volume: 21
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(98)90060-5